[Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].
Identifieur interne : 000067 ( PubMed/Corpus ); précédent : 000066; suivant : 000068[Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].
Auteurs : Lotfi Kochbati ; Chiraz Nasr Ben Ammar ; Farouk Benna ; Monia Hechiche ; Hamouda Boussen ; Mounir Besbes ; Mansour Ben Abdallah ; Khaled Rahal ; Farhat Ben Ayed ; Khaked Ben Romdhane ; Mongi MaalejSource :
- La Tunisie medicale [ 0041-4131 ] ; 2005.
English descriptors
- KwdEn :
- Adenocarcinoma (drug therapy), Adenocarcinoma (pathology), Adenocarcinoma (radiotherapy), Adenocarcinoma (surgery), Adenocarcinoma (therapy), Adult, Aged, Antineoplastic Agents (therapeutic use), Brachytherapy, Carcinoma, Squamous Cell (drug therapy), Carcinoma, Squamous Cell (pathology), Carcinoma, Squamous Cell (radiotherapy), Carcinoma, Squamous Cell (surgery), Carcinoma, Squamous Cell (therapy), Cervix Uteri (pathology), Cisplatin (therapeutic use), Cobalt Radioisotopes (therapeutic use), Combined Modality Therapy, Female, Humans, Hysterectomy, Lymph Node Excision, Middle Aged, Neoplasm Staging, Preoperative Care, Radiotherapy Dosage, Retrospective Studies, Treatment Outcome, Uterine Cervical Neoplasms (drug therapy), Uterine Cervical Neoplasms (pathology), Uterine Cervical Neoplasms (radiotherapy), Uterine Cervical Neoplasms (surgery), Uterine Cervical Neoplasms (therapy).
- MESH :
- chemical , therapeutic use : Antineoplastic Agents, Cisplatin, Cobalt Radioisotopes.
- drug therapy : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- pathology : Adenocarcinoma, Carcinoma, Squamous Cell, Cervix Uteri, Uterine Cervical Neoplasms.
- radiotherapy : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- surgery : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- therapy : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- Adult, Aged, Brachytherapy, Combined Modality Therapy, Female, Humans, Hysterectomy, Lymph Node Excision, Middle Aged, Neoplasm Staging, Preoperative Care, Radiotherapy Dosage, Retrospective Studies, Treatment Outcome.
Abstract
This is a retrospective study of patients treated for cervix cancer staged IB2, IIA or IIB with bulky tumor (> 4cm). Treatment was concurrent radiotherapy (45Gy with 1,8Gy daily fraction) and chemotherapy (5 cycles of Platinum 40mg/m2/week). All patients underwent Brachytherapy (15Gy on the reference isodose according to Paris system) followed by surgery (radical abdominal hysterectomy and bilateral pelvic lymphadenectomy: Piver 3) Between October 1999 and December 2002, forty five patients were treated in this protocol. Median age was 46 years (21- 68). Histology was squamous cell carcinoma in 93% and glandular carcinoma in 7%. Average external radiation dose was 44Gy (20-50). Ninety three percent of patients had at least 3 cycles of chemotherapy and 46,5% received the planned 5 cycles. On the operative specimens, there was 62,5% complete response and only 7 pelvic node involvement (17,5%). Four postoperative complications were noted (one vascular injury, one urinary fistula, one phlebitis and one lymph collection). Preoperative combined radiotherapy and chemotherapy in the early bulky stages of uterine cervix cancer is well tolerated and "gives" a high rate of sterilisation. There was no increase in surgical morbidity.
PubMed: 15929442
Links to Exploration step
pubmed:15929442Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].</title><author><name sortKey="Kochbati, Lotfi" sort="Kochbati, Lotfi" uniqKey="Kochbati L" first="Lotfi" last="Kochbati">Lotfi Kochbati</name><affiliation><nlm:affiliation>Institut Salah Azaiz, Tunis.</nlm:affiliation></affiliation></author><author><name sortKey="Ben Ammar, Chiraz Nasr" sort="Ben Ammar, Chiraz Nasr" uniqKey="Ben Ammar C" first="Chiraz Nasr" last="Ben Ammar">Chiraz Nasr Ben Ammar</name></author><author><name sortKey="Benna, Farouk" sort="Benna, Farouk" uniqKey="Benna F" first="Farouk" last="Benna">Farouk Benna</name></author><author><name sortKey="Hechiche, Monia" sort="Hechiche, Monia" uniqKey="Hechiche M" first="Monia" last="Hechiche">Monia Hechiche</name></author><author><name sortKey="Boussen, Hamouda" sort="Boussen, Hamouda" uniqKey="Boussen H" first="Hamouda" last="Boussen">Hamouda Boussen</name></author><author><name sortKey="Besbes, Mounir" sort="Besbes, Mounir" uniqKey="Besbes M" first="Mounir" last="Besbes">Mounir Besbes</name></author><author><name sortKey="Ben Abdallah, Mansour" sort="Ben Abdallah, Mansour" uniqKey="Ben Abdallah M" first="Mansour" last="Ben Abdallah">Mansour Ben Abdallah</name></author><author><name sortKey="Rahal, Khaled" sort="Rahal, Khaled" uniqKey="Rahal K" first="Khaled" last="Rahal">Khaled Rahal</name></author><author><name sortKey="Ben Ayed, Farhat" sort="Ben Ayed, Farhat" uniqKey="Ben Ayed F" first="Farhat" last="Ben Ayed">Farhat Ben Ayed</name></author><author><name sortKey="Ben Romdhane, Khaked" sort="Ben Romdhane, Khaked" uniqKey="Ben Romdhane K" first="Khaked" last="Ben Romdhane">Khaked Ben Romdhane</name></author><author><name sortKey="Maalej, Mongi" sort="Maalej, Mongi" uniqKey="Maalej M" first="Mongi" last="Maalej">Mongi Maalej</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15929442</idno><idno type="pmid">15929442</idno><idno type="wicri:Area/PubMed/Corpus">000067</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000067</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].</title><author><name sortKey="Kochbati, Lotfi" sort="Kochbati, Lotfi" uniqKey="Kochbati L" first="Lotfi" last="Kochbati">Lotfi Kochbati</name><affiliation><nlm:affiliation>Institut Salah Azaiz, Tunis.</nlm:affiliation></affiliation></author><author><name sortKey="Ben Ammar, Chiraz Nasr" sort="Ben Ammar, Chiraz Nasr" uniqKey="Ben Ammar C" first="Chiraz Nasr" last="Ben Ammar">Chiraz Nasr Ben Ammar</name></author><author><name sortKey="Benna, Farouk" sort="Benna, Farouk" uniqKey="Benna F" first="Farouk" last="Benna">Farouk Benna</name></author><author><name sortKey="Hechiche, Monia" sort="Hechiche, Monia" uniqKey="Hechiche M" first="Monia" last="Hechiche">Monia Hechiche</name></author><author><name sortKey="Boussen, Hamouda" sort="Boussen, Hamouda" uniqKey="Boussen H" first="Hamouda" last="Boussen">Hamouda Boussen</name></author><author><name sortKey="Besbes, Mounir" sort="Besbes, Mounir" uniqKey="Besbes M" first="Mounir" last="Besbes">Mounir Besbes</name></author><author><name sortKey="Ben Abdallah, Mansour" sort="Ben Abdallah, Mansour" uniqKey="Ben Abdallah M" first="Mansour" last="Ben Abdallah">Mansour Ben Abdallah</name></author><author><name sortKey="Rahal, Khaled" sort="Rahal, Khaled" uniqKey="Rahal K" first="Khaled" last="Rahal">Khaled Rahal</name></author><author><name sortKey="Ben Ayed, Farhat" sort="Ben Ayed, Farhat" uniqKey="Ben Ayed F" first="Farhat" last="Ben Ayed">Farhat Ben Ayed</name></author><author><name sortKey="Ben Romdhane, Khaked" sort="Ben Romdhane, Khaked" uniqKey="Ben Romdhane K" first="Khaked" last="Ben Romdhane">Khaked Ben Romdhane</name></author><author><name sortKey="Maalej, Mongi" sort="Maalej, Mongi" uniqKey="Maalej M" first="Mongi" last="Maalej">Mongi Maalej</name></author></analytic><series><title level="j">La Tunisie medicale</title><idno type="ISSN">0041-4131</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (drug therapy)</term><term>Adenocarcinoma (pathology)</term><term>Adenocarcinoma (radiotherapy)</term><term>Adenocarcinoma (surgery)</term><term>Adenocarcinoma (therapy)</term><term>Adult</term><term>Aged</term><term>Antineoplastic Agents (therapeutic use)</term><term>Brachytherapy</term><term>Carcinoma, Squamous Cell (drug therapy)</term><term>Carcinoma, Squamous Cell (pathology)</term><term>Carcinoma, Squamous Cell (radiotherapy)</term><term>Carcinoma, Squamous Cell (surgery)</term><term>Carcinoma, Squamous Cell (therapy)</term><term>Cervix Uteri (pathology)</term><term>Cisplatin (therapeutic use)</term><term>Cobalt Radioisotopes (therapeutic use)</term><term>Combined Modality Therapy</term><term>Female</term><term>Humans</term><term>Hysterectomy</term><term>Lymph Node Excision</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Preoperative Care</term><term>Radiotherapy Dosage</term><term>Retrospective Studies</term><term>Treatment Outcome</term><term>Uterine Cervical Neoplasms (drug therapy)</term><term>Uterine Cervical Neoplasms (pathology)</term><term>Uterine Cervical Neoplasms (radiotherapy)</term><term>Uterine Cervical Neoplasms (surgery)</term><term>Uterine Cervical Neoplasms (therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents</term><term>Cisplatin</term><term>Cobalt Radioisotopes</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Cervix Uteri</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Brachytherapy</term><term>Combined Modality Therapy</term><term>Female</term><term>Humans</term><term>Hysterectomy</term><term>Lymph Node Excision</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Preoperative Care</term><term>Radiotherapy Dosage</term><term>Retrospective Studies</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This is a retrospective study of patients treated for cervix cancer staged IB2, IIA or IIB with bulky tumor (> 4cm). Treatment was concurrent radiotherapy (45Gy with 1,8Gy daily fraction) and chemotherapy (5 cycles of Platinum 40mg/m2/week). All patients underwent Brachytherapy (15Gy on the reference isodose according to Paris system) followed by surgery (radical abdominal hysterectomy and bilateral pelvic lymphadenectomy: Piver 3) Between October 1999 and December 2002, forty five patients were treated in this protocol. Median age was 46 years (21- 68). Histology was squamous cell carcinoma in 93% and glandular carcinoma in 7%. Average external radiation dose was 44Gy (20-50). Ninety three percent of patients had at least 3 cycles of chemotherapy and 46,5% received the planned 5 cycles. On the operative specimens, there was 62,5% complete response and only 7 pelvic node involvement (17,5%). Four postoperative complications were noted (one vascular injury, one urinary fistula, one phlebitis and one lymph collection). Preoperative combined radiotherapy and chemotherapy in the early bulky stages of uterine cervix cancer is well tolerated and "gives" a high rate of sterilisation. There was no increase in surgical morbidity.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15929442</PMID><DateCreated><Year>2005</Year><Month>6</Month><Day>2</Day></DateCreated><DateCompleted><Year>2005</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0041-4131</ISSN><JournalIssue CitedMedium="Print"><Volume>83</Volume><Issue>3</Issue><PubDate><Year>2005</Year><Month>Mar</Month></PubDate></JournalIssue><Title>La Tunisie medicale</Title><ISOAbbreviation>Tunis Med</ISOAbbreviation></Journal><ArticleTitle>[Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].</ArticleTitle><Pagination><MedlinePgn>146-9</MedlinePgn></Pagination><Abstract><AbstractText>This is a retrospective study of patients treated for cervix cancer staged IB2, IIA or IIB with bulky tumor (> 4cm). Treatment was concurrent radiotherapy (45Gy with 1,8Gy daily fraction) and chemotherapy (5 cycles of Platinum 40mg/m2/week). All patients underwent Brachytherapy (15Gy on the reference isodose according to Paris system) followed by surgery (radical abdominal hysterectomy and bilateral pelvic lymphadenectomy: Piver 3) Between October 1999 and December 2002, forty five patients were treated in this protocol. Median age was 46 years (21- 68). Histology was squamous cell carcinoma in 93% and glandular carcinoma in 7%. Average external radiation dose was 44Gy (20-50). Ninety three percent of patients had at least 3 cycles of chemotherapy and 46,5% received the planned 5 cycles. On the operative specimens, there was 62,5% complete response and only 7 pelvic node involvement (17,5%). Four postoperative complications were noted (one vascular injury, one urinary fistula, one phlebitis and one lymph collection). Preoperative combined radiotherapy and chemotherapy in the early bulky stages of uterine cervix cancer is well tolerated and "gives" a high rate of sterilisation. There was no increase in surgical morbidity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kochbati</LastName><ForeName>Lotfi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut Salah Azaiz, Tunis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Ammar</LastName><ForeName>Chiraz Nasr</ForeName><Initials>CN</Initials></Author><Author ValidYN="Y"><LastName>Benna</LastName><ForeName>Farouk</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Hechiche</LastName><ForeName>Monia</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Boussen</LastName><ForeName>Hamouda</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Besbes</LastName><ForeName>Mounir</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ben Abdallah</LastName><ForeName>Mansour</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rahal</LastName><ForeName>Khaled</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Ben Ayed</LastName><ForeName>Farhat</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ben Romdhane</LastName><ForeName>Khaked</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Maalej</LastName><ForeName>Mongi</ForeName><Initials>M</Initials></Author></AuthorList><Language>FRE</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>La radiochimiothérapie concomitante préopératoire dans le cancer du col utérin: résultats préliminaires.</VernacularTitle></Article><MedlineJournalInfo><Country>Tunisia</Country><MedlineTA>Tunis Med</MedlineTA><NlmUniqueID>0413766</NlmUniqueID><ISSNLinking>0041-4131</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003037">Cobalt Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001918" MajorTopicYN="N">Brachytherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002584" MajorTopicYN="N">Cervix Uteri</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003037" MajorTopicYN="N">Cobalt Radioisotopes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007044" MajorTopicYN="N">Hysterectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>6</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>6</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>6</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15929442</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000067 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000067 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= CobaltMaghrebV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:15929442
|texte= [Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15929442" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CobaltMaghrebV1
| This area was generated with Dilib version V0.6.32. |  |